+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Adenovirus-mediated gene transfer of a secreted transforming growth factor-beta type II receptor inhibits luminal loss and constrictive remodeling after coronary angioplasty and enhances adventitial collagen deposition



Adenovirus-mediated gene transfer of a secreted transforming growth factor-beta type II receptor inhibits luminal loss and constrictive remodeling after coronary angioplasty and enhances adventitial collagen deposition



Circulation 104(21): 2595-2601



Background-Extracellular matrix (ECM) remodeling is central to the development of restenosis after coronary angioplasty (PTCA). As a regulator of ECM deposition by vascular cells, substantial evidence implicates transforming growth factor-beta1 (TGF-beta1) in the pathogenesis of restenosis. We investigated the effects of intracoronary expression of a transgenic antagonist of TGF-beta1 on luminal loss after PTCA. Methods and Results-Porcine coronary arteries were randomized to receive a recombinant adenovirus expressing a secreted form of TGF-beta type II receptor (Ad5-RIIs), an adenovirus expressing beta-galactosidase (Ad5-lacZ), or vehicle only by intramural injection at the site of PTCA. Computerized morphometry 28 days after angioplasty revealed a greater minimum luminal area in Ad5-RIIs-injected arteries (1.71+-0.12 mm2) than in the Ad5-lacZ (1.33 +- 0.13 mm2) or vehicle-only (1.08 +- 0.17 mm2, P=0.010 by ANOVA) groups. This was accompanied by greater areas within the internal (P = 0.013) and external (P = 0.031) elastic laminae in Ad5-RIIs-treated vessels. Adventitial collagen content at the site of injury was increased in the Ad5-RIIs group, in contrast to decreases in the Ad5-lacZ and vehicle-only groups (P = 0.004). Conclusions-Adenovirus-mediated antagonism of TGF-beta1 at the site of PTCA reduces lumina loss after PTCA by inhibiting constrictive remodeling. Antagonism of TGF-beta1 stimulates the formation of a dense collagenous adventitia, which prevents constrictive remodeling by acting as an external scaffold. These findings demonstrate the potential of gene therapy-mediated antagonism of TGF-beta1 as prophylactic therapy for restenosis.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 010130795

Download citation: RISBibTeXText

PMID: 11714656


Related references

Adenovirus-Mediated Gene Transfer of a Secreted Transforming Growth Factor- Type Ii Receptor Inhibits Luminal Loss and Constrictive Remodeling After Coronary Angioplasty and Enhances Adventitial Collagen Deposition. Circulation 104(21): 2595-2601, 2001

Adenovirus-mediated gene transfer of transforming growth factor-beta3, but not transforming growth factor-beta1, inhibits constrictive remodeling and reduces luminal loss after coronary angioplasty. Circulation 108(22): 2819-2825, 2003

Adenovirus-mediated transfer of the gene for a truncated Transforming Growth Factor-beta type II receptor at the time of coronary angioplasty reduces luminal loss at 28 days in a porcine model. Journal of the American College of Cardiology 37(2 Suppl. A): 290A, 2001

Adenovirus-Mediated Intra-Coronary Delivery of the Gene for Transforming Growth Factor-β3 (TGF-β3) Reduces Luminal Loss and Inhibits Constrictive Remodelling after Porcine PTCA. Clinical Science 103(S47): 14p.3-14p, 2002

Adenovirus-mediated intra-coronary delivery of the gene for transforming growth factor-beta3 reduces luminal loss and inhibits constrictive remodelling after porcine PTCA. Clinical Science (London) 103(1): 14P, 2002

Periluminal expression of a secreted transforming growth factor-β type II receptor inhibits in-stent neointima formation following adenovirus-mediated stent-based intracoronary gene transfer. Human Gene Therapy 25(5): 443-451, 2014

Inhibition of transforming growth factor-beta by local intravascular gene transfer of a soluble transforming growth factor-beta type II receptor inhibits stent-induced neointima by decreasing extracellular matrix accumulation. European Heart Journal 24(Abstract Suppl.): 339, August-September, 2003

Adenovirus-mediated transfer of a truncated transforming growth factor-beta (TGF-beta) type II receptor completely and specifically abolishes diverse signaling by TGF-beta in vascular wall cells in primary culture. Journal of Biological Chemistry 271(27): 16253-9, 1996

Adenovirus mediated gene transfer of transforming growth factor beta-1 in cultured human RPE. FASEB Journal 9(3): A512, 1995

An increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta receptor type II in scleroderma. Arthritis and Rheumatism 50(5): 1566-1577, 2004

Adenovirus mediated gene transfer of transforming growth factor beta-1 and ornithine aminotransferase in cultured human RPE. Investigative Ophthalmology & Visual Science 36(4): S98, 1995

Adverse effects of adenovirus-mediated gene transfer of human transforming growth factor beta 1 into rabbit knees. Arthritis Research and Therapy 5(3): R132-R139, 2003

Soluble transforming growth factor-beta type II receptor inhibits negative remodeling, fibroblast transdifferentiation, and intimal lesion formation but not endothelial growth. Circulation Research 84(10): 1212-1222, 1999

Adenovirus-mediated transmission of a dominant negative transforming growth factor-beta receptor inhibits in vitro mouse cranial suture fusion. Plastic and Reconstructive Surgery 110(2): 506-514, 2002

Gene transfer of transforming growth factor-beta-1 inhibits intragraft cell mediated immunity. FASEB Journal 9(3): A498, 1995